Frank Verwiel, Director of Intellia Therapeutics NTLA, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/09.

FV

FV

Frank Verwiel

Director

Company

Intellia Therapeutics NTLA

First filing

23/06/16

Trades

9 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Intellia TherapeuticsNTLA	Open-market sale10b5-1 plan	24/06/17	24/06/20	1,505 sh	$25.00	$37,625	−7.7%